Seeing Machines Valuation

Is M2Z undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of M2Z when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: M2Z (€0.03) is trading below our estimate of fair value (€0.25)

Significantly Below Fair Value: M2Z is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for M2Z?

Key metric: As M2Z is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for M2Z. This is calculated by dividing M2Z's market cap by their current revenue.
What is M2Z's PS Ratio?
PS Ratio2.7x
SalesUS$67.63m
Market CapUS$179.57m

Price to Sales Ratio vs Peers

How does M2Z's PS Ratio compare to its peers?

The above table shows the PS ratio for M2Z vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.1x
LPK LPKF Laser & Electronics
1.6x11.6%€210.5m
BSL Basler
0.9x10.4%€163.2m
8UG Q-Free
1.1xn/a€110.4m
M7U Nynomic
1x8.9%€116.0m
M2Z Seeing Machines
2.7x21.4%€142.9m

Price-To-Sales vs Peers: M2Z is expensive based on its Price-To-Sales Ratio (2.7x) compared to the peer average (1.1x).


Price to Sales Ratio vs Industry

How does M2Z's PS Ratio compare vs other companies in the DE Electronic Industry?

4 CompaniesPrice / SalesEstimated GrowthMarket Cap
SCE Schweizer Electronic
0.07x4.3%US$11.87m
UDC UniDevice
0.004x4.6%US$1.94m
7PF0 Syncro Group
0.02xn/aUS$343.86k
UDC UniDevice
0.0004xn/aUS$157.96k
No more companies available in this PS range
M2Z 2.7xIndustry Avg. 0.9xNo. of Companies4PS00.40.81.21.62+
4 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: M2Z is expensive based on its Price-To-Sales Ratio (2.7x) compared to the European Electronic industry average (0.9x).


Price to Sales Ratio vs Fair Ratio

What is M2Z's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

M2Z PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2.7x
Fair PS Ratio1x

Price-To-Sales vs Fair Ratio: M2Z is expensive based on its Price-To-Sales Ratio (2.7x) compared to the estimated Fair Price-To-Sales Ratio (1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst M2Z forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€0.027
€0.11
+309.5%
24.0%€0.14€0.084n/a2
Nov ’25€0.029
€0.11
+282.8%
24.0%€0.14€0.083n/a2
Oct ’25€0.05
€0.13
+157.5%
16.1%€0.16€0.11n/a3
Sep ’25€0.05
€0.13
+153.4%
15.9%€0.15€0.11n/a3
Aug ’25€0.05
€0.13
+150.4%
16.8%€0.15€0.10n/a3
Jul ’25€0.041
€0.14
+239.6%
10.4%€0.15€0.12n/a3
Jun ’25€0.038
€0.14
+280.8%
16.1%€0.17€0.12n/a3
May ’25€0.04
€0.14
+261.4%
16.5%€0.18€0.12n/a3
Apr ’25€0.048
€0.14
+200.2%
16.8%€0.18€0.12n/a3
Mar ’25€0.046
€0.14
+210.9%
16.8%€0.18€0.12n/a3
Feb ’25€0.052
€0.14
+174.9%
16.0%€0.17€0.12n/a3
Jan ’25€0.043
€0.14
+233.9%
16.6%€0.17€0.11n/a3
Dec ’24€0.053
€0.14
+167.3%
16.8%€0.17€0.12n/a3
Nov ’24€0.051
€0.14
+180.7%
17.0%€0.17€0.12€0.0293
Oct ’24€0.055
€0.13
+135.4%
11.1%€0.14€0.12€0.052
Sep ’24€0.058
€0.17
+200.9%
36.7%€0.28€0.11€0.054
Aug ’24€0.061
€0.17
+182.0%
34.9%€0.27€0.12€0.054
Jul ’24€0.06
€0.17
+190.4%
31.8%€0.28€0.12€0.0415
Jun ’24€0.065
€0.17
+164.2%
32.2%€0.27€0.11€0.0385
May ’24€0.056
€0.18
+217.1%
30.9%€0.26€0.11€0.044
Apr ’24€0.055
€0.18
+221.5%
30.9%€0.26€0.11€0.0484
Mar ’24€0.088
€0.19
+111.6%
31.0%€0.27€0.11€0.0464
Feb ’24€0.07
€0.19
+169.3%
30.6%€0.27€0.11€0.0524
Jan ’24€0.059
€0.19
+227.3%
31.4%€0.28€0.11€0.0434
Dec ’23€0.066
€0.19
+192.3%
31.4%€0.28€0.11€0.0534
Nov ’23€0.069
€0.20
+186.1%
27.0%€0.28€0.14€0.0514

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies